GQ1b ganglioside antibodiesGuillain-Barré syndromeMiller Fisher syndromeataxiaophthalmoparesis
Figures from the paper
Abstract (AI)
Miller Fisher's syndrome is a rare variant of Guillain-Barré's syndrome characterized by the acute development of ataxia, ophthalmoparesis, and areflexia. Most patients have a measureable antibody in serum directed against the GQ1b ganglioside. This antibody is also present in the serum of patients with other forms of Guillain-Barré's syndrome who have prominent ataxia or ophthalmoplegia as part of their clinical presentation. Miller Fisher's syndrome generally is self-limited and has an excellent prognosis.
Key Findings
1
Anti-GQ1b antibodies also occur in other Guillain–Barré syndrome forms featuring prominent ataxia or ophthalmoplegia.
2
Miller Fisher syndrome is a rare Guillain–Barré syndrome variant presenting acutely with ataxia, ophthalmoparesis, and areflexia.
3
Miller Fisher syndrome is generally self-limited and associated with an excellent prognosis.
4
Most patients have measurable serum antibodies directed against the GQ1b ganglioside.
Research Object
Miller Fisher syndrome
Research Subject
Clinical characteristics, anti-GQ1b antibody association, and prognosis
Publication Details
Publication Date
2013-05-15
Journal
Publisher
ISSN
Cited by
78
Access Type
Author Information
Download PDF
Subscribe to digest